Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

U.S. imposes sanctions on Argentina-based online pharmacies for opioids

Published 2019-05-23, 12:16 p/m
Updated 2019-05-23, 12:20 p/m
© Reuters.  U.S. imposes sanctions on Argentina-based online pharmacies for opioids

WASHINGTON, May 23 (Reuters) - The U.S. Treasury Department on Thursday placed sanctions on Goldpharma, an Argentina-based network of online pharmacies that it said contributed to the opioid crisis by selling clandestinely produced narcotics to customers in the United States.

The Treasury's Office of Foreign Assets Control also designated eight Argentine nationals and nine entities located in Argentina, Colombia, Canada, Britain and the Netherlands for their roles in Goldpharma, the agency said in a statement.

"The Goldpharma network illustrates the sophisticated tactics drug traffickers and money launderers use to capitalize on the Internet and online pharmacy sites to sell highly addictive illicit narcotics around the world," said Sigal Mandelker, Treasury under secretary for terrorism and financial intelligence.

Goldpharma websites sell both legitimate and clandestinely produced narcotics, including oxycodone, hydrocodone, and tramadol, without a prescription, the statement said. They sell the vast majority of their illicit opioids to customers in the United States, it said.

The move was the latest effort by the Trump Administration to tackle the U.S. epidemic of abuse and overdoses linked to prescription painkillers and other opioids like heroin.

Opioids were involved in a record 47,600 overdose deaths in 2017 in the United States, according to the U.S. Centers for Disease Control and Prevention.

Five of the Argentine designated individuals have been indicted in the U.S. District Court for the Eastern District of Wisconsin for their role in Goldpharma, the statement said. Three others were involved in Goldpharma's money laundering activities, it said.

Seven U.S. companies owned or controlled by designated members of Goldpharma have also been blocked, the statement said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Goldpharma was identified as a drug trafficking and money laundering organization under the Foreign Narcotics Kingpin Designation Act, the statement said.

Any property of the designated persons in the United States would be blocked and U.S. persons would be prohibited from business dealings with them, it said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.